Related Experiment Video

Updated: May 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Obesity in the ageing man

K Michalakis1, D G Goulis, A Vazaiou

  • 1First Department of Internal Medicine, National and Kapodestrian University of Athens, School of Medicine, "Laiko" General Hospital, Athens, Greece.

Metabolism: Clinical and Experimental
|July 9, 2013
PubMed

Keywords:
ACTHARCBMBMIBMRBTCCKCNSCRHDHEADHEASDHTDM2FFMFTFT(3)FT(4)GHGHBHGHRHGnRHHDLIGF 2IGF1IRLHLOHMMMSNPYPAI 1PPTPYYRMRSHBGSMSSTT(3)T(4)TBWTNFTRHTSHTTWCWHOWHRWorld Health Organizationadrenocorticotropic hormoneageingarcuate nucleusbasal metabolic ratebioavailable testosteronebody massbody mass indexcentral nervous systemcholecystokinincorticotrophin releasing hormonedehydroepiandrosteronedehydroepiandrosterone sulfatediabetes mellitus type 2dihydrotestosteronefat free massfree testosteronefree thyroxinefree triiodothyroninegonadotropin releasing hormonegrowth hormonegrowth hormone binding proteingrowth hormone releasing hormonehigh density lipoproteinhormonal changesinsulin like growth factor 1insulin like growth factor 2insulin resistancelate onset hypogonadismluteinising hormonemanmetabolic syndromemuscle massneuropeptide Yobesitypeptide tyrosine tyrosineplasminogen activator inhibitor 1post prandial thermogenesisrT(3)resting metabolic ratereverse triiodothyroninesex hormone binding globulinskeletal masssomatostatintestosteronethyroid stimulating hormonethyrotropine releasing hormonethyroxinetotal body watertotal testosteronetriiodothyroninetumor necrosis factorwaist circumferencewaist to hip ratio

More Related Videos

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Decellularization-Based Quantification of Skeletal Muscle Fatty Infiltration10:37

Decellularization-Based Quantification of Skeletal Muscle Fatty Infiltration

Published on: June 9, 2023

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...